Correction to: KSR1 regulates BRCA1 degradation and inhibits breast cancer growth

Stebbing J 1 , Zhang H 1 , Xu Y 1 , Lit LC 1 , Green AR 2 , Grothey A 1 Show all authors , Lombardo Y 1 , Periyasamy M 1 , Blighe K 3 , Zhang W 4 , Shaw JA 3 , Ellis IO 5 , Lenz HJ 4 , Giamas G 6

Affiliations 

  • 1 Division of Cancer, Department of Surgery and Cancer, Imperial College London, Imperial College Centre for Translational and Experimental Medicine, Hammersmith Hospital Campus, London, UK
  • 2 Department of Cellular Pathology, Queen's Medical Centre, Nottingham University Hospital NHS Trust, Nottingham, UK
  • 3 Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester, UK
  • 4 Division of Medical Oncology, University of Southern California, Norris Comprehensive Cancer Centre, Keck School of Medicine, Los Angeles, CA, USA
  • 5 Faculty of Medicine, Department of Physiology, University of Malaya, Kuala, Lumpur, Malaysia
  • 6 Division of Cancer, Department of Surgery and Cancer, Imperial College London, Imperial College Centre for Translational and Experimental Medicine, Hammersmith Hospital Campus, London, UK. g.giamas@imperial.ac.uk
Oncogene, 2021 May;40(19):3473.
PMID: 33888869 DOI: 10.1038/s41388-021-01759-9

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications